欧康维视生物-B(01477)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

01477 欧康维视生物-B

已收盘 12-08 16:08:10

8.320

+0.020

+0.24%

最高8.400	最低8.140	成交量55.25万
今开8.400	昨收8.300	日振幅3.13%
总市值67.81亿	流通市值67.81亿	总股本8.15亿
成交额455.39万	换手率0.07%	流通股本8.15亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"01477","market":"HK","secType":"STK","nameCN":"欧康维视生物-B","latestPrice":8.32,"timestamp":1765181290003,"preClose":8.3,"halted":0,"volume":552500,"delay":0,"floatShares":815000000,"shares":815000000,"eps":-0.43195262520035477,"marketStatus":"已收盘","change":0.02,"latestTime":"12-08 16:08:10","open":8.4,"high":8.4,"low":8.14,"amount":4553940,"amplitude":0.031325,"askPrice":8.32,"askSize":500,"bidPrice":8.27,"bidSize":500,"shortable":3,"etf":0,"ttmEps":-0.36646675576165944,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1765243800000},"marketStatusCode":5,"adr":0,"listingDate":1594310400000,"exchange":"SEHK","adjPreClose":8.3,"openAndCloseTimeList":[[1765157400000,1765166400000],[1765170000000,1765180800000]],"volumeRatio":0.750679,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01477","defaultTab":"news","newsList":[{"id":"2589366863","title":"歌礼制药-B(01672)：ASC30治疗肥胖症的13周II期研究取得积极的顶线结果","url":"https://stock-news.laohu8.com/highlight/detail?id=2589366863","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589366863?lang=zh_cn&edition=full","pubTime":"2025-12-08 17:33","pubTimestamp":1765186385,"startTime":"0","endTime":"0","summary":"智通财经APP讯，歌礼制药-B 公布，评估口服小分子GLP-1受体 激动剂ASC30治疗肥胖症的13周II期研究取得积极的顶线结果。在主要终点上，60毫克ASC30的经安慰剂校正后的平均体重下降高达7.7%。在稳态下，ASC30的血药浓度随剂量增加而增加。该ASC30 II期研究因不良事件导致的总体停药率为4.8%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1378846.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01477","01672","BK1515","BK1574","BK1161","BK1191"],"gpt_icon":0},{"id":"2589533373","title":"兆科眼科-B(06622)拟与东生华制药于台湾地区共同推进BRIMOCHOL™PF的临床导论及未来商业化","url":"https://stock-news.laohu8.com/highlight/detail?id=2589533373","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589533373?lang=zh_cn&edition=full","pubTime":"2025-12-08 16:48","pubTimestamp":1765183700,"startTime":"0","endTime":"0","summary":"智通财经APP讯，兆科眼科-B 公布，公司与以台湾为基地的东生华制药股份有限公司订立策略性伙伴关系，于台湾地区共同推进BRIMOCHOL PF的临床导论及未来商业化。东生华制药精于慢性病及精准医疗，提供安全而易于获取的照护解决方案。根据协议条款，兆科授予东生华制药以独家分销商身份于台湾地区注册、进口、推广、分销、营销及销售BRIMOCHOL PF的权利。于2025年6月，兆科的伙伴兼BRIMOCHOL PF的开发商Tenpoint Therapeutics, Ltd.宣布，美国FDA已受理该药品的新药上市申请。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1378791.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06622","BK1574","BK1587","01477","BK1583","BK1191"],"gpt_icon":0},{"id":"2589382248","title":"永顺泰：麦芽在食品制药领域需求量相对较小","url":"https://stock-news.laohu8.com/highlight/detail?id=2589382248","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589382248?lang=zh_cn&edition=full","pubTime":"2025-12-08 15:06","pubTimestamp":1765177582,"startTime":"0","endTime":"0","summary":"证券之星消息，永顺泰(001338)12月08日在投资者关系平台上答复投资者关心的问题。投资者提问：除啤酒酿造外，永顺泰麦芽在食品、制药等大消费新兴领域的需求规模及市场开拓进展如何？永顺泰回复：麦芽在食品、制药等大消费新兴领域的应用目前需求量相对较小。麦芽绝大部分用于啤酒酿造，也可用于威士忌酿造、食品、制药等领域。公司目前主要的销售对象是啤酒酿造企业。公司未来将根据市场需求变化，持续优化产品结构，探索新的应用场景。谢谢关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120800012352.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0215","01477","BK1191","BK1574","001338"],"gpt_icon":0},{"id":"2589381237","title":"歌礼制药-B(01672.HK)涨超4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2589381237","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589381237?lang=zh_cn&edition=full","pubTime":"2025-12-08 13:56","pubTimestamp":1765173414,"startTime":"0","endTime":"0","summary":"每经AI快讯，歌礼制药-B(01672.HK)涨超4%，截至发稿涨4.25%，报14.23港元，成交额2682.71万港元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202512083585200140.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202512083585200140.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1515","01477","BK1191","BK1161","BK1574","01672"],"gpt_icon":0},{"id":"2589389033","title":"港股异动 | 歌礼制药-B(01672)涨超4% 1 类新药地尼法司他片上市申请获得受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2589389033","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589389033?lang=zh_cn&edition=full","pubTime":"2025-12-08 13:42","pubTimestamp":1765172527,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，歌礼制药-B涨超4%，截至发稿，涨4.25%，报14.23港元，成交额2682.71万港元。消息面上，12月4日，CDE 官网显示，歌礼的1类新药地尼法司他片上市申请获得受理。根据该药的临床研究进度，Insight 数据库推测本次申请的适应症为用于治疗中重度寻常性痤疮。兴业证券此前指出，歌礼制药在减重代谢领域持续投入，聚焦减重赛道核心痛点进行深度管线布局。公司引进的痤疮治疗药物ASC40也有望逐渐为公司贡献收入。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1378689.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1515","01477","BK1191","BK1161","BK1574","01672"],"gpt_icon":0},{"id":"2589870297","title":"因塞特制药药物在某类血癌治疗中展现积极效果","url":"https://stock-news.laohu8.com/highlight/detail?id=2589870297","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589870297?lang=zh_cn&edition=full","pubTime":"2025-12-07 23:35","pubTimestamp":1765121722,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK1574","01477","BK1191"],"gpt_icon":0},{"id":"2589894822","title":"歌礼制药-B12月05日获主力加仓112.8万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2589894822","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589894822?lang=zh_cn&edition=full","pubTime":"2025-12-05 16:16","pubTimestamp":1764922563,"startTime":"0","endTime":"0","summary":"12月05日, 歌礼制药-B股价涨3.33%，报收13.65元，成交金额3875.7万元，换手率0.29%，振幅5.07%，量比0.48。歌礼制药-B今日主力资金净流入112.8万元，连续3日净流入，上一交易日主力净流入2.1万元。近一年数据显示，该股主力连续3日净流入后，次日上涨概率为71.43%，平均涨幅为6.09%。该股近5个交易日下跌7.04%，主力资金累计净流入53.8万元；近20日主力资金累计净流入5412.2万元，其中净流入天数为15日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251205162249952c6dba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251205162249952c6dba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","01672","BK1515","BK1161","01477","BK1191"],"gpt_icon":0},{"id":"2588974838","title":"高光制药冲刺港股：半年营收1亿亏1亿 刚完成1.6亿融资，估值25亿","url":"https://stock-news.laohu8.com/highlight/detail?id=2588974838","media":"雷递网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588974838?lang=zh_cn&edition=full","pubTime":"2025-12-04 22:34","pubTimestamp":1764858882,"startTime":"0","endTime":"0","summary":"杭州高光制药股份有限公司（简称：“高光制药”）日前递交招股书，准备在港交所上市。高光制药2025年上半年营收为1.07亿元，期内亏损为1.9亿元，","market":"sh","thumbnail":"https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20251204/6390048447884519559177454.jpeg","type":0,"news_type":0,"thumbnails":["https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20251204/6390048447884519559177454.jpeg"],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.leinews.com/n32017/detail.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"leinews_highlight","symbols":["01477"],"gpt_icon":0},{"id":"2588887952","title":"高光制药向港交所提交上市申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2588887952","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588887952?lang=zh_cn&edition=full","pubTime":"2025-12-04 21:37","pubTimestamp":1764855420,"startTime":"0","endTime":"0","summary":"据港交所文件，杭州高光制药股份有限公司-B向港交所提交上市申请书，联席保荐人为中金公司、招银国际。(本文来自第一财经)\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/jjxw/2025-12-04/doc-infzrzsu0231870.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2025-12-04/doc-infzrzsu0231870.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1574","01477","HEXmain","BK1191"],"gpt_icon":0},{"id":"2588884617","title":"河化股份：子公司产品应用于医药制药行业","url":"https://stock-news.laohu8.com/highlight/detail?id=2588884617","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588884617?lang=zh_cn&edition=full","pubTime":"2025-12-04 20:52","pubTimestamp":1764852725,"startTime":"0","endTime":"0","summary":"证券之星消息，河化股份(000953)12月03日在投资者关系平台上答复投资者关心的问题。投资者提问：请问贵公司精细类化工可以应用在哪些领域？河化股份回复：您好！公司子公司南松医药的医药中间体等精细化工产品，主要应用于医药制药等行业。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120400036952.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0010","BK0239","BK1161","BK0066","BK0004","BK0077","BK1191","159938","BK1574","09939","01477","BK0071","000953","BK1515"],"gpt_icon":0},{"id":"2588884381","title":"*ST国华：控股子公司未参与获取山东北大高科华泰制药股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2588884381","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588884381?lang=zh_cn&edition=full","pubTime":"2025-12-04 20:48","pubTimestamp":1764852502,"startTime":"0","endTime":"0","summary":"证券之星消息，*ST国华12月03日在投资者关系平台上答复投资者关心的问题。9月30日前，要求其解除与青海制药的代理协议，2026年1月22日前，向无关联关系的第三方转让其间接持有的山东华泰制药股份。*ST国华回复：尊敬的投资者您好，公司控股子公司深圳国科稚健医药有限公司未参与获取山东北大高科华泰制药有限公司股权，公司如有重大交易将根据相关规则及时进行披露，请以公司披露的公告为准，感谢您的关注，谢谢。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120400036772.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0231","BK1191","BK1574","000004","01477","BK0086","BK0077"],"gpt_icon":0},{"id":"2588005060","title":"歌礼制药-B(01672)12月4日斥资2093.89万港元回购162万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2588005060","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588005060?lang=zh_cn&edition=full","pubTime":"2025-12-04 17:39","pubTimestamp":1764841165,"startTime":"0","endTime":"0","summary":"智通财经APP讯，歌礼制药-B(01672)发布公告，于2025年12月4日该公司斥资2093.89万港元回购162万股，回购价格为每股12.33-13.23港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1377737.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","BK1515","BK1574","01672","BK1191","01477"],"gpt_icon":0},{"id":"1135614851","title":"歐康維視生物（01477）11月股份變動月報表：股本維持穩定","url":"https://stock-news.laohu8.com/highlight/detail?id=1135614851","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1135614851?lang=zh_cn&edition=full","pubTime":"2025-12-04 17:13","pubTimestamp":1764839589,"startTime":"0","endTime":"0","summary":"歐康維視生物于2025年12月4日发布2025年11月股份变动月报表。报告期截至2025年11月30日，公司法定股本维持不变，已发行股份数及库存股份数亦无新增发行或回购变动。但报告期内并无因期权行使或奖励归属而新增发行或转让股份，亦无购回与注销活动。截至11月末，公司整体股本结构保持稳定。公司于公告中确认，所有股份发行及激励活动均遵守香港联交所上市规则及适用法律法规。公告由公司董事Lian Yong CHEN签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01477"],"gpt_icon":0},{"id":"2588886999","title":"每日卖空追踪 | 欧康维视生物-B 12月04日卖空量成交3.75万股，卖空比例为6.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588886999","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588886999?lang=zh_cn&edition=full","pubTime":"2025-12-04 16:30","pubTimestamp":1764837023,"startTime":"0","endTime":"0","summary":"欧康维视生物-B北京时间12月04日，涨3.93%，卖空量成交3.75万股，较上一交易日减少74.05%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204163254a72357c2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204163254a72357c2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1574","01477"],"gpt_icon":0},{"id":"1184350727","title":"港股生物医药股表现活跃！心玮医疗-B涨近5%，歌礼制药-B涨超4%","url":"https://stock-news.laohu8.com/highlight/detail?id=1184350727","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1184350727?lang=zh_cn&edition=full","pubTime":"2025-12-04 09:43","pubTimestamp":1764812582,"startTime":"0","endTime":"0","summary":"12月4日，港股$生物(000504)$医药股盘初表现活跃，$心玮医疗-B(06609)$涨近5%，$歌礼制药-B(01672)$涨超4%，$嘉和生物-B(06998)$涨近3%，$康方生物(09926)$、$荣昌生物(09995)$涨超2%>>","market":"hk","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"78017fe3ba4f859116cb01c02d313574","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BPRC5H50.USD","09926","BK1191","IE00B543WZ88.USD","LU2399975544.HKD","LU1969619763.USD","LU0634319403.HKD","LU1720050803.USD","LU0348783233.USD","LU0348827113.USD","LU1794554557.SGD","06609","LU0348784397.USD","LU2476274308.USD","BK1574","BK1583","LU1961090484.USD","LU0348767384.USD","LU0348735423.USD","LU0348825331.USD","LU0417516738.SGD","06998","BK1100","LU0348766576.USD","LU0561508036.HKD","LU2488822045.USD","BK1587","09939","01477","LU2778985437.USD","01672","09995","BK1161","LU0417516902.SGD","LU2328871848.SGD","LU2476274720.SGD","LU0540923850.HKD","LU0417516571.SGD","IE00B5MMRT66.SGD","BK1515"],"gpt_icon":0},{"id":"2588014565","title":"歌礼制药-B(01672)12月3日斥资1592.75万港元回购130.6万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2588014565","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588014565?lang=zh_cn&edition=full","pubTime":"2025-12-03 17:22","pubTimestamp":1764753729,"startTime":"0","endTime":"0","summary":"智通财经APP讯，歌礼制药-B(01672)发布公告，于2025年12月3日，该公司斥资1592.75万港元回购130.6万股股份，每股回购价格为11.68-12.48港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1377080.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","01477","BK1191","BK1515","01672","BK1574"],"gpt_icon":0},{"id":"2588048012","title":"每日卖空追踪 | 歌礼制药-B 12月03日卖空量成交23.3万股，卖空比例为1.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588048012","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588048012?lang=zh_cn&edition=full","pubTime":"2025-12-03 16:30","pubTimestamp":1764750621,"startTime":"0","endTime":"0","summary":"歌礼制药-B北京时间12月03日，跌12.51%，卖空量成交23.3万股，较上一交易日增加80.62%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251203163321a7210dee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251203163321a7210dee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1574","BK1161","01672","01477","BK1515"],"gpt_icon":0},{"id":"2588675025","title":"欧康维视生物-B12月03日遭主力抛售29.2万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2588675025","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588675025?lang=zh_cn&edition=full","pubTime":"2025-12-03 16:16","pubTimestamp":1764749768,"startTime":"0","endTime":"0","summary":"12月03日, 欧康维视生物-B股价跌0.50%，报收7.89元，成交金额405.3万元，换手率0.06%，振幅2.14%，量比0.45。欧康维视生物-B今日主力资金净流出29.2万元，连续5日净流出，上一交易日主力净流出209.6万元。该股近5个交易日上涨0.25%，主力资金累计净流出451.3万元；近20日主力资金累计净流出745.8万元，其中净流出天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251203162316a4c9e7fc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251203162316a4c9e7fc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","01477","BK1574"],"gpt_icon":0},{"id":"2588343016","title":"创新药概念持续调整 歌礼制药(01672)跌逾1成 机构指仿制药下降趋势无法避免 影响制药行业","url":"https://stock-news.laohu8.com/highlight/detail?id=2588343016","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588343016?lang=zh_cn&edition=full","pubTime":"2025-12-03 16:08","pubTimestamp":1764749332,"startTime":"0","endTime":"0","summary":"金吾财讯 | 创新药概念持续调整，临近收盘，歌礼制药(01672)跌11.1%，圣诺医药(02257)跌10.9%，信达生物(01801)跌2.72%，药明生物(02269)跌1.8%，百济神州(06160)跌1.35%。国元国际指出，医药行业目前已经进行了十一批国家药品集中带量采购以及多轮医保谈判，随着药品带量采购的常态化进行，仿制药行业的下降趋势无法避免，对制药行业有一定的影响。2025年1-9月医药制造业实现营业收入同比略下降2.0%，利润总额同比略下降0.7%，整体比较平稳。受集采、医保谈判的影响，仿制药的前景平淡，未来行业的发展需要创新药来推动增长。","market":"us","thumbnail":"https://static.szfiu.com/news/20241108/ZDQyZmM0MDNhYTRlOWFhOWE0NDBjZGFmOTc4ZmU3NDQzMjc2MzA4MTk4NA==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/ZDQyZmM0MDNhYTRlOWFhOWE0NDBjZGFmOTc4ZmU3NDQzMjc2MzA4MTk4NA==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1970832","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01801","LU3063872942.SGD","BK1576","02257","159992","SG9999002562.SGD","LU0502904849.HKD","LU0140636845.USD","IE00B0JY6N72.USD","LU2097828714.EUR","01672","LU1688375341.USD","LU2097828805.USD","LU0327786744.USD","HK0000165453.HKD","LU1242518857.USD","LU0307460666.USD","LU0181495838.USD","LU1242518931.SGD","BK1610","LU0417516902.SGD","06160","06978","BK1141","BK1191","LU0979878070.USD","BK1521","01477","LU1794554557.SGD","LU2097828631.EUR","LU0052750758.USD","LU2097828474.EUR","LU0588546209.SGD","LU0051755006.USD","LU0417516738.SGD","02269","LU2488822045.USD","LU0823426308.USD","LU0516423174.USD","LU0039217434.USD","LU0455707207.USD","LU1720050803.USD","LU1880383366.USD","LU0819121731.USD","LU2039709279.SGD","LU0516422440.USD","LU0516422952.EUR","BK1161","LU1303224171.USD","LU1770034418.SGD"],"gpt_icon":0},{"id":"2588690013","title":"港股生物技术板块尾盘持续走低","url":"https://stock-news.laohu8.com/highlight/detail?id=2588690013","media":"南方财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588690013?lang=zh_cn&edition=full","pubTime":"2025-12-03 15:22","pubTimestamp":1764746550,"startTime":"0","endTime":"0","summary":"港股生物技术板块尾盘持续走低","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"31dd9809785dff9f5258c6a127eaa10f","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202512033581486026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["02197","01672","BK1191","BK1515","BK1574","01477","BK1161"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ocumension.com","stockEarnings":[{"period":"1week","weight":0.0122},{"period":"1month","weight":-0.0247},{"period":"3month","weight":-0.2095},{"period":"6month","weight":0.0836},{"period":"1year","weight":0.6275},{"period":"ytd","weight":0.8444}],"compareEarnings":[{"period":"1week","weight":0.0087},{"period":"1month","weight":0.0058},{"period":"3month","weight":0.0262},{"period":"6month","weight":0.0964},{"period":"1year","weight":0.3336},{"period":"ytd","weight":0.3004}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"欧康维视生物是一家控股公司，主要从事眼科治疗药物的研发和商业化。该公司主要产品包括OT-401 (YUTIQ)、OT-1001 (ZERVIATE)、OT-502 (DEXYCU)、OT-301 (NCX 470)、OT-101和OT-202等。该公司业务主要在国内市场开展。","yearOnYearQuotes":[{"month":1,"riseRate":0.2,"avgChangeRate":-0.116968},{"month":2,"riseRate":0.4,"avgChangeRate":-0.049128},{"month":3,"riseRate":0.6,"avgChangeRate":0.058111},{"month":4,"riseRate":0.4,"avgChangeRate":0.017956},{"month":5,"riseRate":0.6,"avgChangeRate":0.137077},{"month":6,"riseRate":0.8,"avgChangeRate":0.129408},{"month":7,"riseRate":0.4,"avgChangeRate":-0.027707},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.064893},{"month":9,"riseRate":0.166667,"avgChangeRate":-0.082685},{"month":10,"riseRate":0.166667,"avgChangeRate":-0.121217},{"month":11,"riseRate":0.333333,"avgChangeRate":0.004503},{"month":12,"riseRate":0.666667,"avgChangeRate":0.076381}],"exchange":"SEHK","name":"欧康维视生物-B","nameEN":"OCUMENSION-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.10","shortVersion":"4.35.10","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"欧康维视生物-B(01477)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供欧康维视生物-B(01477)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"欧康维视生物-B,01477,欧康维视生物-B股票,欧康维视生物-B股票老虎,欧康维视生物-B股票老虎国际,欧康维视生物-B行情,欧康维视生物-B股票行情,欧康维视生物-B股价,欧康维视生物-B股市,欧康维视生物-B股票价格,欧康维视生物-B股票交易,欧康维视生物-B股票购买,欧康维视生物-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"欧康维视生物-B(01477)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供欧康维视生物-B(01477)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}